Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chubb
Cerilliant
Citi
Express Scripts
Fuji
Baxter
UBS
Argus Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

NORMIFLO Drug Profile

« Back to Dashboard

When do Normiflo patents expire, and what generic alternatives are available?

Normiflo is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in NORMIFLO is ardeparin sodium. Additional details are available on the ardeparin sodium profile page.
Summary for NORMIFLO
Drug patent expirations by year for NORMIFLO
Synonyms for NORMIFLO
1108625-99-5
1108626-06-7
1K5KDI46KZ
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
3-[(5-{[6-carboxy-4,5-dihydroxy-3-(sulfooxy)oxan-2-yl]oxy}-6-(hydroxymethyl)-3-(sulfoamino)-4-(sulfooxy)oxan-2-yl)oxy]-6-({5-acetamido-4,6-dihydroxy-2-[(sulfooxy)methyl]oxan-3-yl}oxy)-4-hydroxy-5-(sulfooxy)oxane-2-carboxylic
4QW4AN84NQ
5R0L1D739E
6-[(6-{[2-CARBOXY-6-({5-ACETAMIDO-4,6-DIHYDROXY-2-[(SULFOOXY)METHYL]OXAN-3-YL}OXY)-4-HYDROXY-5-(SULFOOXY)OXAN-3-YL]OXY}-2-(HYDROXYMETHYL)-5-(SULFOAMINO)-4-(SULFOOXY)OXAN-3-YL)OXY]-3,4-DIHYDROXY-5-(SULFOOXY)OXANE-2-CARBOXYLIC
6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[5-(6-carboxy-4,5-dihydroxy-3-sulfooxyoxan-2-yl)oxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-4-hydroxy-5-sulfooxyoxane-2-carboxylic acid
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
7UQ7X4Y489
9005-49-6
9816XA9004
AC1L19ZN
Adomiparin [USAN]
AKOS032944890
Ardeparin
AVE-5026
CA000816
CA000817
CA011199
CA012298
Clexane
Clexane (TN)
CS-3075
D00RQU
D0MX5S
DTXSID80872762
E47C0NF7LV
EMT 967
EMT-966
EMT-967
EMT966
EMT967
enoxaparin
Enoxaparine
GTPL6811
heparin
Heparin [BAN]
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
HY-17567
Lipo-hepin
LMWH
LMWH/SNAD (solid oral), Emisphere
Lovenox
Lovenox (TN)
Lovenox HP
Low molecular weight heparin
Low molecular weight heparin (solid oral, eligen)
Low molecular weight heparin (solid oral, eligen), Emisphere
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
M 118
M 118REH
M316WT19D8
NOCAS_872762
P776JQ4R2F
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
RP-54563
S79O08V79F
SCHEMBL543122
SEMULOPARIN
Semuloparin [USAN:INN]
T2410KM04A
UNII-1K5KDI46KZ
UNII-4QW4AN84NQ
UNII-5R0L1D739E
UNII-7UQ7X4Y489
UNII-9816XA9004
UNII-M316WT19D8
UNII-P776JQ4R2F
UNII-S79O08V79F
UNII-V72OT3K19I
UNII-VL0L558GCB
V72OT3K19I
VL0L558GCB

US Patents and Regulatory Information for NORMIFLO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn NORMIFLO ardeparin sodium INJECTABLE;INJECTION 020227-002 May 23, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn NORMIFLO ardeparin sodium INJECTABLE;INJECTION 020227-001 May 23, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Teva
Mallinckrodt
US Army
Covington
Chubb
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.